Skip to main content

News and Events

Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

17 Results

Filters

Selected Filters

17 Results

Reviewing RECOVER’s impact in 2024

In 2024, RECOVER continued to advance scientific understanding of Long COVID through observational studies, clinical trials, and community engagement.

Feature
Clinical Trial Observational EHR Pathobiology Adult Pediatric Pregnant Women

NIH adds funds to Long COVID research, advances work on new clinical trials

The $662 million in funds received in 2024 will ensure that researchers can continue making progress toward understanding, diagnosing, preventing, and treating Long COVID through 2029.

News Release
Clinical Trial Observational EHR Pathobiology Adult Pediatric Pregnant Women

RECOVER Research Update: November 2024

Recent findings from across RECOVER’s five research areas could improve our ability to identify people with Long COVID, understand the underlying causes of their symptoms, and provide them with care and treatment.

Research Update
Observational EHR Pathobiology Adult Pediatric Pregnant Women

RECOVER Research Update: August 2024

Six new RECOVER research publications report findings from the initiative’s pathobiology, observational, and electronic health record (EHR) studies.

Research Update
Observational EHR Pathobiology Adult

Routine lab tests are not a reliable way to diagnose Long COVID

Findings from this RECOVER study will inform future efforts to develop tools for diagnosing Long COVID.

News Release
Observational Pathobiology Adult

Leadership Q&A: NIH to bolster RECOVER Long COVID research efforts

Gary Gibbons, M.D., Walter Koroshetz, M.D., and Jeanne Marrazzo, M.D., M.P.H. of the NIH answer questions about investing an additional $515 million in RECOVER's Long COVID research efforts.

Q&A
Clinical Trial EHR Observational Pathobiology Tissue Pathology Adult Pediatric Pregnant Women

NIH to bolster RECOVER Long COVID research efforts through infusion of $515 million

This additional funding will build on and continue RECOVER's work to improve our understanding of and ability to diagnose, prevent, and treat Long COVID.

News Release
Clinical Trial EHR Observational Pathobiology Tissue Pathology Adult Pediatric Pregnant Women

Changes in the body provide clues for the development of Long COVID

A research team that includes RECOVER researchers found changes in the immune systems of people with Long COVID.
News Release
Pathobiology Adult